$25.55+0.12 (+0.47%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Collegium Pharmaceutical (COLL) Institutional Ownership
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
Sources Ownership filingsQuarter ended How we compute thisNot investment advice
1 figure withheld by our checks. Each blank figure names its reason.
13F fund flowQuarter ended Sep 30, 2026*: more funds trimmed or exited than added or entered, mild distribution (37 new · 85 increased · 91 reduced · 74 closed). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 239 filers, Sep 30, 2026
# 13F FUNDS
239
13F VALUE
$803.1M
36.8M shares
Withheld: the 13F filers report more shares than the company has outstanding, which happens when shared or lent shares are counted twice. The filer count, shares and value are as filed.
Insider trades · latest filings (Form 4)routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | SANTINI GINO | director | Acquired · Option exercise | 8,700 | $16.49 | ↗ |
| Jun 8, 2026 | SANTINI GINO | director | Disposed · Option exercise | 8,700Stock Option (Right to Purchase) | — | ↗ |
| May 18, 2026 | Freund John Gordon | director | Disposed · Open-market sale | 20 | $34.05 | ↗ |
| May 15, 2026 | Freund John Gordon | director | Acquired · Option exercise | 8,700 | $16.49 | ↗ |
| May 15, 2026 | Freund John Gordon | director | Disposed · Open-market sale | 4,127 | $34.54 | ↗ |
| May 15, 2026 | Freund John Gordon | director | Disposed · Option exercise | 8,700Stock Option (Right to Purchase) | — | ↗ |
| May 14, 2026 | Glancy Donovan Michael | director | Acquired · Grant / award | 17,482 | — | ↗ |
| May 14, 2026 | Balice-Gordon Rita J. | director | Acquired · Grant / award | 8,741 | — | ↗ |
| May 14, 2026 | Paya Carlos V | director | Acquired · Grant / award | 8,741 | — | ↗ |
| May 14, 2026 | Lurker Nancy | director | Acquired · Grant / award | 8,741 | — | ↗ |
| May 14, 2026 | Freund John Gordon | director | Acquired · Grant / award | 8,741 | — | ↗ |
| May 14, 2026 | SANTINI GINO | director | Acquired · Grant / award | 8,741 | — | ↗ |
| May 14, 2026 | BOHLIN GAREN G | director | Acquired · Grant / award | 8,741 | — | ↗ |
| May 13, 2026 | Lurker Nancy | director | Disposed · Open-market sale | 4,500 | $35.97 | ↗ |
| May 11, 2026 | BOHLIN GAREN G | director | Acquired · Option exercise | 8,700 | $16.49 | ↗ |
| May 11, 2026 | BOHLIN GAREN G | director | Disposed · Open-market sale | 8,700 | $37.18 | ↗ |
| May 11, 2026 | BOHLIN GAREN G | director | Disposed · Option exercise | 8,700Stock Option (Right to Purchase) | — | ↗ |
| Mar 18, 2026 | Dieter David | EVP & General Counsel | Disposed · Open-market sale | 13,976 | $34.92 | ↗ |
| Mar 17, 2026 | Dieter David | EVP & General Counsel | Disposed · Tax withholding | 8,840 | $35.72 | ↗ |
| Mar 9, 2026 | Dieter David | EVP & General Counsel | Disposed · Open-market sale | 6,224 | $36.65 | ↗ |
* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How many 13F filers hold Collegium Pharmaceutical?
Collegium Pharmaceutical was held by 239 13F filers as of Sep 30, 2026.
Not investment advice.

